The size of the Latin America Enteral Feeding Devices Market was worth USD 0.26 billion in 2022 and estimated to be growing at a CAGR of 4.45%, to reach USD 0.32 billion by 2027.
The enteral feeding devices market observes a rising acceptance of technologically innovative, user-friendly safety systems that diminish difficulties such as misconnections, tube dislodgements, and tube blockage. As a result, numerous manufacturers in the Enteral Feeding Devices market also increasingly employ safety techniques to safeguard the patient.
A growing number of hospitals and ambulatory care services are approving enteral nutrition as an efficient clinical nutrition system.
The growth of the Latin American Enteral Feeding Devices Market is mainly driven by an increase in the prevalence of chronic diseases, an increase in the number of pre-term births, and a rising aging population. Given the expected demographic shift towards an aging population, the prevalence of diseases and disorders primarily affecting the elderly is expected to increase. The Latin American population is characteristically aging, with a steady increase in the population aged 60 and over.
Advances in health diagnosis and treatment techniques have dramatically increased the life expectancy of patients suffering from several chronic or serious diseases and conditions. According to the WHO, around 8.2 million people died of cancer in 2015, which is the origin of the patient group for enteral feeding devices. Additionally, in oncological applications, enteral feeding devices play an important role in palliative treatment options, including HNC and esophageal cancer. Premature births have declined in Latin America since peaking at 12.8% in 20010. As a result, the growth of the pediatric enteral feeding devices market is expected to be positively affected.
However, there are certain complications associated with using these devices, which result in additional health care costs. Most complications associated with enteral feeding are minor, but some can be very serious. In addition, bacterial contamination due to enteral feeding is also expected to limit the market growth.
This research report on the Latin America enteral feeding devices market has been segmented and sub-segmented into the following categories:
By Product Type:
By End User:
Geographically, the Brazilian enteral feeding devices market dominated the enteral feeding devices market in Latin America in 2020 and is expected to be growing at a promising CAGR during the forecast period due to the increasing prevalence of chronic diseases such as neurological and gastrointestinal disorders, increasing of the sick population requiring food improvement of the country's health infrastructure. The World Journal of Gastroenterology conducted a study to assess the prevalence of gastrointestinal disorders in Brazil. According to the study, more than 22% of participants reported gastrointestinal upset. In addition, in 2017, around 1.7 million people in Brazil had dementia, and the growth in dementia cases has been significant, with an increase of 97% over the past 10 years. Many people with these chronic diseases would need enteral nutrition to cover their daily nutritional intake.
KEY MARKET PLAYERS:
Companies playing a prominent role in the Latin America enteral feeding devices market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org